Click to view your profile
Click to search for condition or expert
Click to open main menu
Renal Cell Carcinoma (RCC) Latest Advances
Find the Latest Research About Renal Cell Carcinoma (RCC)
Save
Bookmark
Share
Share
Overview
Find a Doctor
Latest Advances
Clinical Trials
Treatments
Customize your search results with filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 01/06/2023
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 837 publications
See more filters
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma.
Condition:
Metastatic Renal Cell Carcinoma (mRCC)
Journal:
Anti-cancer drugs
Treatment Used:
Proton-Pump Inhibitors (PPIs) with Tyrosine Kinase Inhibitors (TKIs)
Number of Patients:
301
Published:
December 20, 2022
VIEW PUBLICATION
Efficacy and safety of vorolanib plus everolimus in metastatic renal cell carcinoma: A three-arm, randomised, double-blind, multicentre phase III study (CONCEPT).
Condition:
Metastatic Renal Cell Carcinoma (RCC)
Journal:
European journal of cancer (Oxford, England : 1990)
Treatment Used:
Vorolanib Plus Everolimus
Number of Patients:
399
Published:
December 02, 2022
VIEW PUBLICATION
5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma: an individual patient data meta-analysis from IROCK (the International Radiosurgery Consortium of the Kidney).
Condition:
Primary Renal Cell Carcinoma
Journal:
The Lancet. Oncology
Treatment Used:
Stereotactic Ablative Body Radiotherapy (SABR)
Number of Patients:
190
Published:
November 18, 2022
VIEW PUBLICATION
Nivolumab plus ipilimumab plus cabozantinib triplet combination for patients with previously untreated advanced renal cell carcinoma: Results from a discontinued arm of the phase III CheckMate 9ER trial.
Condition:
Advanced Renal Cell Carcinoma (aRCC)
Journal:
European journal of cancer (Oxford, England : 1990)
Treatment Used:
Combination Nivolumab, Ipilimumab, and Cabozantinib
Number of Patients:
50
Published:
November 03, 2022
VIEW PUBLICATION
Outcome and surgical management of symptomatic renal angiomyolipoma in Ibadan, Nigeria, Sub-Saharan Africa.
Condition:
Renal Angiomyolipoma
Journal:
Nigerian journal of clinical practice
Treatment Used:
Surgery
Number of Patients:
3
Published:
October 29, 2022
VIEW PUBLICATION
Clear Cell Renal Cell Carcinoma, Diagnostic and Therapeutic Difficulties, Case Report and Literature Review.
Condition:
Clear Cell Renal Cell Carcinoma (RCC)
Journal:
Medicina (Kaunas, Lithuania)
Treatment Used:
Sunitinib and Nivolumab
Number of Patients:
1
Published:
October 27, 2022
VIEW PUBLICATION
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors.
Condition:
Japanese Patients with Advanced Solid Tumors
Journal:
Cancer chemotherapy and pharmacology
Treatment Used:
Lenvatinib Plus Pembrolizumab
Number of Patients:
6
Published:
October 26, 2022
VIEW PUBLICATION
Long-term survival after pulmonary metastasectomy in patients with esophageal squamous cell carcinoma with lung metastasis.
Condition:
Esophageal Squamous Cell Carcinoma with Lung Metastasis
Journal:
Journal of cardiothoracic surgery
Treatment Used:
Pulmonary Metastasectomy
Number of Patients:
44
Published:
October 14, 2022
VIEW PUBLICATION
Re-Administration of Pembrolizumab for Urothelial Carcinoma after immune-Related Myasthenia Gravis : A Case Report.
Condition:
Urothelial Carcinoma after Immune-Related Myasthenia Gravis
Journal:
Hinyokika kiyo. Acta urologica Japonica
Treatment Used:
Pembrolizumab
Number of Patients:
1
Published:
October 06, 2022
VIEW PUBLICATION
Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database.
Condition:
Facial Angiofibroma Related to Tuberous Sclerosis Complex (TSC)
Journal:
Orphanet journal of rare diseases
Treatment Used:
Topical and Systemic mTOR Inhibitor
Number of Patients:
2057
Published:
September 14, 2022
VIEW PUBLICATION
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial.
Condition:
Advanced Renal Cell Carcinoma (aRCC)
Journal:
BMJ open
Treatment Used:
Nivolumab Plus Ipilimumab Alternating with Nivolumab Monotherapy
Number of Patients:
106
Published:
September 14, 2022
VIEW PUBLICATION
A Case of Renal Anastomosing Hemangioma.
Condition:
Renal Anastomosing Hemangioma
Journal:
Hinyokika kiyo. Acta urologica Japonica
Treatment Used:
Robot-Assisted Laparoscopic Partial Nephrectomy
Number of Patients:
1
Published:
September 07, 2022
VIEW PUBLICATION
Showing 1-12 of 837
Next
Last Updated: 01/06/2023